Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 23 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Kountouras, Jannis and Keyword is Fatty Liver [Clear All Filters]
(2017).
Activin A and follistatin in patients with nonalcoholic fatty liver disease..
Metabolism. 65(10), 1550-8.
(2016). Homocysteine in nonalcoholic steatohepatitis: A reply..
Eur J Intern Med. 35, e40-e41.
(2016). Helicobacter pylori infection, insulin resistance and nonalcoholic fatty liver disease..
Med Hypotheses. 82(6), 795.
(2014). Helicobacter pylori might contribute to nonalcoholic fatty liver disease-related cardiovascular events by releasing prothrombotic and proinflammatory factors..
Hepatology. 60(4), 1450-1.
(2014). Irisin in patients with nonalcoholic fatty liver disease..
Metabolism. 63(2), 207-17.
(2014).
(2014). Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index..
Ann Hepatol. 12(5), 749-57.
(2013). Helicobacter pylori infection in patients with nonalcoholic fatty liver disease..
Metabolism. 62(1), 121-6.
(2013). A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study..
Biomarkers. 18(7), 607-13.
(2013). Serum visfatin in nonalcoholic fatty liver disease..
Ann Hepatol. 13(1), 150-1.
(2013). Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease..
Hormones (Athens). 12(3), 405-16.
(2013). Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease..
J Clin Gastroenterol. 46(4), 272-84.
(2012). Serum homocysteine levels in patients with nonalcoholic fatty liver disease..
Ann Hepatol. 11(1), 68-76.
(2012). Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease..
Int J Food Sci Nutr. 63(6), 659-66.
(2012). Sulfated oxysterols as candidates for the treatment of nonalcoholic fatty liver disease..
Metabolism. 61(6), 755-8.
(2012). Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease..
J Renin Angiotensin Aldosterone Syst. 12(4), 498-503.
(2011). The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature..
J Clin Gastroenterol. 45(1), 50-4.
(2011). Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis..
Metabolism. 60(3), 313-26.
(2011). Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin..
Med Hypotheses. 74(6), 1089-90.
(2010). Nonlinear distribution of adiponectin in patients with nonalcoholic fatty liver disease limits its use in linear regression analysis..
J Clin Gastroenterol. 44(3), 229-30; author reply 230-1.
(2010). The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease..
Diabetes Obes Metab. 12(5), 365-83.
(2010). Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines..
Curr Mol Med. 9(3), 299-314.
(2009).